Recent Updates
Recently added Catalysts
RDNT

RadNet Reports First Quarter Financial Results and Adjusts Upwards 2015 Guidance Ranges Despite more severe weather conditions in the east coast this quarter as compared with last year's first quart

Key Takeaway: RadNet Reports First Quarter Financial Results and Adjusts Upwards 2015 Guidance Ranges California, May 11, 2015 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 2

Full Press Release Details

RadNet Reports First Quarter Financial
Results and Adjusts Upwards 2015 Guidance Ranges
California, May 11, 2015 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality,
cost-effective, fixed-site outpatient diagnostic imaging services through a network of 267 (inclusive of the eight New York Radiology
Partners facilities recently acquired) owned and/or operated outpatient imaging centers, today reported financial results
for its first quarter of 2015.
Dr. Howard Berger, President and Chief Executive
Officer of RadNet, commented, "Similar to last year's first quarter, we faced severe winter weather conditions in our
northeastern and mid-Atlantic operations. Specifically, we estimate that our EBITDA was impacted by $2.8 million more than last
year's quarter. We were also significantly impacted by investments we made in the first quarter to ready the Company to service
increasing volumes in southern California. These included increased staffing levels in our front office, scheduling and pre-authorization
departments, the installation of a new time and attendance system, the acceleration of the eRAD IT implementation, the completion
of our migration to voice recognition transcription and the construction of several new locations. Although these activities greatly
increased our expenses during the quarter, we believe they were necessary to prepare us for future growth. I expect to see our
expenses normalize relative to our revenue during the remainder of the year."
"We experienced extraordinary procedural
growth in our southern California operations, totaling 17.4% relative to last year's first quarter. Much of this growth resulted
from capitation contracts we signed in the last 4 months, which included the responsibility to service a large population of managed
Medicaid patients. Although these contracts will be extremely valuable to us in the future, we experienced unusually high utilization
of services during the quarter. We believe this is because many of these patients are new to the healthcare delivery system, which
resulted in pent-up demand for imaging. We expect utilization to decrease in the coming months, which will lower our operating
expenses in the future. Furthermore, we expect to receive rate increases from some of our contracted medical groups to compensate
us for the higher than anticipated utilization we experienced," added Dr. Berger.
For the first quarter of 2015, RadNet reported
Revenue of $181.3 million, Adjusted EBITDA(1) of $20.2 million and Net Loss of $4.6 million, respectively. Revenue
increased $12.4 million (or 7.3%), Adjusted EBITDA(1) decreased $7.5 million (or 27.0%) and Net Loss (excluding
the tax adjusted loss from the extinguishment of debt in 2014) increased $3.5 million, respectively, over the first quarter of
2014. Per share Net Loss for the first quarter was $(0.11), compared to a loss in the first quarter
of 2014 of $(0.03) (excluding the tax adjusted loss from the extinguishment of debt in 2014),
based upon a weighted average number of basic and diluted shares outstanding of 42.7 million and 40.0 million for these periods
in 2015 and 2014, respectively. Interest expense decreased $1.8 million relative to the first quarter of 2014, and stock-based
compensation expense increased $2.5 million during the first quarter of 2015.
in the first quarter of 2015 were certain non-cash expenses and non-recurring items including: $3.6 million of non-cash employee
stock compensation expense resulting from the vesting of certain options and restricted stock; $36,000 of severance paid
in connection with headcount reductions related to cost savings initiatives; $38,000 gain on the sale of certain capital equipment;
and $1.3 million of combined non-cash amortization and write-off of Deferred Financing Expense and discount
on issuance and refinance of debt related to financing fees paid as part of our existing credit facilities.
For the first quarter of 2015, as compared
to the prior year's first quarter, MRI volume increased 8.4%, CT volume increased 19.8% and PET/CT volume increased 3.3%.
Overall volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams, increased
8.6% over the prior year's first quarter. On a same-center basis, including only those centers which were part of RadNet
for both the first quarters of 2015 and 2014, MRI volume increased 6.1%, CT volume increased 16.9% and PET/CT volume increased
3.0%. Overall same-center volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other
exams, increased 5.5% over the prior year's same quarter.
2015 Guidance Update
RadNet updates the previously announced 2015 fiscal year guidance
Original 2015 Guidance New 2015 Guidance Change
Revenue (a) $745 million - $765 million $785 million - $805 million +$40 million
Adjusted EBITDA (1) $123 million - $133 million $125 million - $135 million +$2 million
Capital Expenditures (b) $40 million - $45 million $40 million - $45 million Unchanged
Cash Interest Expense $34 million - $38 million $36 million - $40 million +$2 million
Free Cash Flow Generation (c) $40 million - $50 million $42 million - $52 million +$2 million
Dr. Berger highlighted, "We have updated
our guidance to incorporate both the expected financial contribution of the New York Radiology Partners acquisition and the first
quarter results, which were significantly affected by winter weather conditions and certain investments we made for future growth.
The result is that we have increased our Revenue, Adjusted EBITDA and Free Cash Flow guidance levels for the year."
Dr. Berger added, "The revised expectations
also reflect my confidence that we can meet our original projections for our base business during the remainder of 2015. I'm
happy to report that our April top-line results appear to be strong. In particular, we noted the continuation of robust procedural
volumes in our west coast operations and about 5% same-center procedure growth in our east coast operations relative to March."
Conference Call for Today
Dr. Howard Berger, President and Chief Executive
Officer, and Mark Stolper, Executive Vice President and Chief Financial Officer, will host a conference call to discuss its first
quarter 2015 results on Monday, May 11th, 2015 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).
Conference Call Details:
Date: Monday, May 11, 2015
Time: 10:30 a.m. Eastern Time
Dial In-Number: 888-708-5692
International Dial-In Number: 913-312-1473
It is recommended that participants dial in
approximately 5 to 10 minutes prior to the start of the 10:30 a.m. call. There will also be simultaneous and archived webcasts
under the "Investors" menu section and "News Releases" sub-menu of the website. An archived replay of
the call will also be available and can be accessed by dialing 877-870-5176 from the U.S., or 858-384-5517 for international callers,
and using the passcode 6621088.
Regulation G: GAAP and Non-GAAP Financial
This release contains certain financial information
not reported in accordance with GAAP. The Company uses both GAAP and non-GAAP metrics to measure its financial results. The Company
believes that, in addition to GAAP metrics, these non-GAAP metrics assist the Company in measuring its cash-based performance.
The Company believes this information is useful to investors and other interested parties because it removes unusual and nonrecurring
charges that occur in the affected period and provides a basis for measuring the Company's financial condition against other quarters.
Such information should not be considered as a substitute for any measures calculated in accordance with GAAP, and may not be comparable
to other similarly titled measures of other companies. Non-GAAP financial measures should not be considered in isolation from,
or as a substitute for, financial information prepared in accordance with GAAP. Reconciliation of this information to the most
comparable GAAP measures is included in this release in the tables which follow.
RadNet, Inc. is the leading national provider of freestanding, fixed-site
diagnostic imaging services in the United States based on the number of locations and annual imaging revenue. RadNet has a network
of 267 owned and/or operated outpatient imaging centers. RadNet's core markets include California, Maryland, Delaware, New Jersey,
New York and Rhode Island. Together with affiliated radiologists, and inclusive of full-time and per diem employees and technicians,
RadNet has a total of approximately 6,300 employees. For more information, visit http://www.radnet.com.
This press release contains forward-looking
statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Specifically, statements concerning
successfully integrating acquired operations, successfully achieving 2015 financial guidance, successfully developing and integrating
new lines of business, continuing to grow its business by generating patient referrals and contracts with radiology practices,
and receiving third-party reimbursement for diagnostic imaging services, are forward-looking statements within the meaning of the
Safe Harbor. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks and
uncertainties, which may cause the Company's actual results to differ materially from the statements contained herein. Further
information on potential risk factors that could affect RadNet's business and its financial results are detailed in its most recent
Annual Report on Form 10-K, as filed with the Securities and Exchange Commission. Undue reliance should not be placed on forward-looking
statements, especially guidance on future financial performance, which speaks only as of the date they are made. RadNet undertakes
no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date
they were made, or to reflect the occurrence of unanticipated events.
Mark Stolper, 310-445-2800
Executive Vice President and
Chief Financial Officer
Last updated: May 11, 2015